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Summary.-Sera obtained in 1969 from 956 unselected elderly persons in Busselton,
Western Australia were tested for carcinoembryonic antigen (CEA) by a " double
antibody " microradioimmunoassay. Forty-four (4-5%) were positive for CEA
(5 ng/ml or greater). Review of health records for the 4-year period subsequent to
accession of sera showed that 6 (14%) of the 44 persons positive for CEA dled of CEA
associated cancers, 15 were heavy smokers, 2 had colonic diverticula and 1 a peptic
ulcer. On the other hand, 18 (2%) of the 912 persons negative for CEA developed
CEA associated cancers. Thus, a significantly greater proportion of cancers (P=
0-01) was found in the persons positive for CEA. Furthermore, when 21 persons
who were positive for CEA in 1969, but clinically well 4 years later, were examined
2 had occult cancer of lung and colon respectively. However, the relatively low
yield of diagnosis of cancer from our present population survey led to the conclusion
that, if screening for cancer were to be solely dependent on testing for CEA, increased
specificity and sensitivity of test systems should be awaited.
THE RELIABILITY of radioimmuno-
assays for carcinoembryonic antigen
(CEA) as an indicator ofcancer is accepted
in certain situations; high levels strongly
suggest this diagnosis (LoGerfo, Krupey
and Hansen, 1971; Laurence et al., 1972),
and prompt and sustained disappearance
post-operatively indicates complete sur-
gical excision (Thomson et al., 1969;
Zamcheck et al., 1972). There are, how-
ever, two major areas ofuncertainty in the
application of testing for CEA. Is it
useful for the routine diagnosis of cancer
in the clinic, and will population screening
be rewarding? We report here the results
of studies to determine first the incidence
ofCEA in serum ofthe elderly segment of
the population of the Australian town of
Busselton and second the relevance of a
positive test for CEA to the occurrence of
cancer in the subsequent 4 years.
MATERIALS AND METHODS
Population survey.-The subjects were all
persons who in 1969 lived in the shire of
Busselton, Western Australia. This com-
munity constitutes a non-transient, pre-
dominantly Western European farming
population which, since 1966, has been the
subject of ongoing health surveys conducted
by the Busselton Population Studies Group
(Curnow et al., 1969). Every 3 years a
vigorous publicity campaign has been
mounted inthe area to enlistthe participation
of the entire community in the survey.
Consequently, 89% ofthe adult population of
4100 persons participated in the survey
conducted in 1969.
The 1969 survey consisted of a compre-
* Publication No. 1993 from The Walter and Eliza Hall Institute of Medical Research.
t Present Address: Department ofMedicine, University Hospitals of Cleveland, Cleveland, Ohio 44106,
U.S.A.
Correspondence to Dr I. R. Mackay, Clinical Research Unit, The Walter and Eliza Hall Institute of
Medical Research, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia.
11D. P. STEVENS, I. R. MACKAY AND K. J. CULLEN
hensive questionnaire, physiological testing,
including electrocardiogram and pulmonary
function, and collection of a venous blood
specimen upon which multiple biochemical
and serological analyses could be performed
(Curnow et al., 1969). Coded frozen serum
specimens were transported by air to
Melbourne where they were stored at -20°C
until assayed for CEA in 1973, except for
temporary thawing for other studies. Most
sera had been thawed and refrozen twice
before testing for CEA while some 10% had
been thawed up to 6 times before testing. Of
the sera obtained from the 977 persons aged
60 years or over who were bled in 1969, 956
were available in 1973 for testing for CEA.
The ages and sexes of the subjects are
described in Table I.
TABLE I.-The Age and Sex of 956
Persons Studiedfor the Presence of CEA
in Serum
Age
60-69
70-79
80-89
>90
Total
Male
307
153
40
1
501
Female
290
133
30
2
455
Smoking history.-The health question-
naire which was administered at the time of
venesection in 1969 included an enquiry into
smoking habits. Each participant was asked
whether he was a current smoker, former
smoker or non-smoker; the method of
smoking, i.e. cigarettes, pipe or cigars; and
the quantity smoked per day. Those who
smoked 15 or more cigarettes per day were
designated heavy smokers.
Clinical status after testing for CEA. The
primary medical care of 90% of the subjects
tested for CEA has been provided by one of
us (K.C.). Since care was provided by the
same primary physician for all subjects, both
CEA-positive and CEA-negative groups were
given equal attention.
Without knowledge of the results of
testing for CEA, a review was made of the
health of these subjects for the period from
1969 to 1973. Information was available
from medical practice records, a tumour and
death registry, and the Busselton Survey
which was conducted in 1972. Information
was obtained regarding the appearance of
cancer of any type, non-neoplastic disease of
the gastrointestinal system and death by any
cause. Cancers were arbitrarily divided into
2 groups onthe basis ofthe reportedincidence
of CEA in serum of persons with clinically
demonstrable cancer (LoGerfo et at., 1971;
Zamcheck et al., 1972; Laurence et al., 1972);
those in which the reported incidence ofCEA
in serum exceeded 50% positive were
designated " CEA associated " cancers (colon,
lung, stomach, liver, pancreas and breast),
and all others were designated as " non-CEA
associated ", although most are associated
with some increase in incidence of CEA in
serum, albeit lower than 50%. All diagnoses
of CEA associated cancer in the Busselton
population were confirmed by histological
examination.
The review of medical records was
retrospective. No special investigations
were performed to demonstrate occult CEA
related diseases. Diseases were recognized
when they became clinically apparent or were
discovered as a result of investigations
which were thought by the subject's local
practitioner to be indicated on the basis ofhis
clinical judgement or accepted local clinical
practice. The results of testing for CEA
were not known during the period of surveil-
lance.
Recall and examination of CEA-positive
subjects.-In early 1974, all persons who had a
positive test for CEA in 1969 and who were
still alive were recalled for further clinical
investigations. They were informed of the
results of testing in 1969 and were asked to
complete a brief questionnaire. A physical
examination and radiological examinations of
the chest and colon were performed.
Microradioimmunoassay for CEA.-CEA
was tested for bv " double antibody " type of
microradioimmunoassay (MacSween et al.,
1972; MacSween, Warner and Mackay, 1973);
the reliability of this test and comparability
of results with those from other test systems
have been presented in previous publications
(MacSween et al., 1972, 1973; Stevens et al.,
1973; Khoo and Mackay, 1973). It was
particularly suitable for the present study
because only small volumes of sera were
available for testing. This assay depends on
the inhibition by CEA in 0-025 ml of whole
serum with binding of 1251-CEA by specific
anti-CEA antiserum raised in the goat and
used at a dilution of 5x 10-4. The purified
CEA employed in these tests was provided by
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diluted 8x 10-3 was added to the anti-CEA
antiserum to block complexing of the latter
by anti-goat substances found in some
human sera (MacSween et al., 1973). Specific
anti-goat gamma globulin antiserum raised
in the rabbit and diluted to 10-2 was used to
precipate the CEA-anti-CEA complexes and
after centrifugation, the supernatants were
counted in a gamma spectrometer. Control
tubes in each assay consisted of doubling
dilutions of purified CEA diluted in pooled
normal human sera, 1251-CEA alone, and
1251-CEA plus anti-CEA. The " cut-off"
level of positivity in this assay is 5 ng/ml
(Khoo and Mackay, 1973).
Direct comparison of this method was
made with the assay of LoGerfo et al. (1971)
which employs extraction of plasma with
perchloric acid before testing and precipi-
tation of complexes in zirconyl phosphate gel
(Z-gel). Results for the 2 methods on 50
coded serum samples showed concordance in
36; in the remainder, there were low levels of
CEA activity by the Z-gel method, the mean
of 14 sera being 4-8 ng/ml, but specimens
were recorded as negative by the double
antibody technique (Stevens and McPherson,
unpublished).
RESULTS
CEA levels in Busselton sera of 1969
The range oflevels ofCEA in serum for
the 956 subjects tested is shown in Table
II. Forty-four (4-5%) gave values of
5 ng/ml or greater; most ranged from 5 to
9 ng/ml and 6 gave values of 20 ng/ml or
greater.
Health statu,s of subjects after testingfor
CEA
Cancer. During the 4-year period of
observation, " CEA associated " cancers
developed in 6 (14%) of the 44 persons
whose sera of 1969 were positive for CEA
and 18 (2%) ofthe 912 in whose sera CEA
was undetectable. The increased inci-
dence of these cancers in persons with
detectable CEA in serum in 1969 was
statistically significant (P 0-01).
However, it was ascertained that 3 ofthe 6
cancers in CEA-positive persons had been
suspected by other methods before 1969
so that, in fact, 3 CEA-positive persons
without known cancer in 1969 ultimately
developed a " CEA associated " cancer in
the 4-year period of surveillance. On the
other hand, none of the 18 cancers that
developed in the CEA-negative group had
been diagnosed at the time of the 1969
survey.
" Non-CEA associated" cancers
occurred with no greater frequency in
CEA-positive than in CEA-negative
subjects (Table II).
TABLE II. Levels ofCEA in the sera of956Persons aged 60 Years and Over
in 1969 in Comparison with their Health Statu,s in the 4 Years Subsequent to
Testing
Health status: 1969-73 (No. of persons)
CEA
associated
cancer*
(P= 0-01)§
18
1 (2**)
1
2
2
Non-CEA
associated
cancert
34
1
1
0
0
Heavy
cigarette
smoking
(P <0 001)
95
10**
2
2
Non-neoplastic
lesions of G.I.
system:
(N.S.)
44
1
0
11
* Includes cancer of colon, stomach, lung, pancreas, liver and breast.
t Includes basal cell and squamous cell carcinoma of skin, leukaemia, osteosarcoma and carcinomata of
prostate, bladder and kidney.
t Colonic diverticula, gastric ulcer, duodenal ulcer, hiatus hernia, cholecystitis, cirrhosis and ulcerative
colitis.
§ Figures in parentheses reflect comparison between CEA-posiltive (5 ng/ml or greater) and CEA-negative
groups by the Poisson method for comparison of unequal sample sizes; N.S. = not significant.
The same person.
** 2 persons found to have occult malignancy in 1974 by radiographic screening.
CEA in 1969
Serum
level
(ng/ml)
<5
5-9
10-14
15-19
>20
No.
with
level
912
23
12
3
6
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Non-neoplastic conditions including
cigarette -smoking.-Of non-neoplastic
conditions previously shown to be asso-
ciated with CEA, only heavy cigarette
smoking was significantly (P<0- 001)
more prevalent among the 38 CEA-
positive persons who did not develop
cancer (Table II), as previously reported
(Stevens et al., 1973). Colonic diverticula
became apparent in 2 persons and duo-
denal ulcer in 1 (a heavy smoker) whose
sera were positive for CEA in 1969.
Neither of these conditions occurred
significantly more frequently among
persons who were positive for CEA
(Table II). Death from non-neoplastic
causes occurred at approximately the
same frequency in both groups.
Patients lost to follow up.-Follow-up
data were not available for 81 persons of
whom 2 were in the CEA-positive group.
Follow-up examinations of CEA-positive
subjects
Of the 44 persons positive for CEA in
1969, 32 were alive and available for study
in early 1974. Twenty-one of these
consented to further investigation. Of
these 21, 2 were found to have radio-
graphically detectable but asymptomatic
cancer, one a bronchogenic carcinoma, the
other an adenocarcinoma of the sigmoid
colon. Both were heavy smokers in 1969
when found to be positive for CEA.
DISCUSSION
The incidence of a positive test for
CEA in serum by " double antibody "
microradioimmunoassay in an unselected
elderly segment (aged 60 years and over)
of an Australian population was 4.5%
(44 of 956 persons). Of this positive
group, during the 4-year follow-up period,
6 persons (14%) died from a CEA asso-
ciated cancer while 18 (43%) were free of
symptomatic cancer but had conditions
possibly accounting for CEA in serum
including heavy cigarette smoking
(Stevens et al., 1973), colonic diverticula
and peptic ulcer. Moreover, a further 2
persons, from a group of 21 re-examined 4
years after showing a positive test for
CEA, were demonstrated by x-ray to have
occult asymptomatic cancer of the lung
and colon, respectively. In 20 (2%) ofthe
956 elderly persons examined, there was
no discernible cause for a positive test for
CEA.
A positive test for CEA in heavy
smokers and persons with inflammatory
diseases of the pulmonary and gastro-
intestinal systems has uncertain signi-
ficance. This appears to be a "false
positive " reaction with regard to cancer
detection, but may represent an index of
increased risk for the development of
cancer. It is of interest, in this regard,
that cancer was detected radiologically in
2 asymptomatic persons, both heavy
smokers, 4 years after their giving a
positive test for CEA. Comparable
investigation to ascertain the incidence of
occult cancer in the symptomless CEA-
negative heavy smoker group was not
considered to be justifiable.
There are several possible interpre-
tations for a positive test for CEA in those
without cancer or a smoking history inthis
elderly population. These would include
conditions not now known to be associated
with CEA, small or clinicallylatent cancers
which were not disclosed because other
specific cancer screening techniques were
not employed, or advanced age of itself,
which may predispose to elevation of
CEA in serum (Zamcheck et al., 1972).
Possibly the non-extraction of sera with
perchloric acid in our double antibody
method may have resulted in false
positive results due to substances in
serum which cross-react with CEA.
However, our double antibody method, in
comparison with the Z-gel method, in fact
proved to be a slightly less sensitive
indicator of CEA reactivity in serum and
hence would detect fewer CEA positive
subjects.
Population testing for CEA is clearly
epidemiologically relevant to the subse-
quent occurrence of cancer, as judged by
the significantly larger proportion of
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deaths from CEA associated cancer in
Busselton subjects whose sera were posi-
tive for CEA in 1969. Also, the recog-
nition ofoccult cancer 4 years after testing
for CEA in 2 of 21 CEA-positive subjects
examined raises the interesting and hope-
ful possibility for the individual subject
that a positive test for CEA is indicative
of an increased risk of later development
of cancer. On the other hand, the overall
yield of 8 cancers appears too low to
justify extensive diagnostic assessments
of all CEA positive subjects detected by
the present CEA test procedure.
Hence we conclude that the present
status of CEA testing must remain that
of an adjunct to conventional methods
of cancer diagnosis and, if population
screening for cancer were to be solely
dependent on testing for CEA, this
should await the development of in-
creased specificity and sensitivity of test
systems.
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